The evaluation of the Preparing For Life early childhood Intervention programme
| ISRCTN | ISRCTN04631728 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN04631728 |
| Secondary identifying numbers | N/A |
- Submission date
- 07/06/2013
- Registration date
- 20/06/2013
- Last edited
- 01/05/2024
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Other
Plain English summary of protocol
Background and study aims
This study is to test the effectiveness of the Preparing for Life (PFL) programme which aims to improve school readiness and life outcomes of socioeconomically disadvantaged children. The programme is operating in several disadvantaged communities in Dublin with above national average rates of unemployment, early school leavers, lone parent households and social housing. The PFL programme, which began in 2008, works with families right from pregnancy until school entry to promote positive child development through improved parental behaviour and social support.
Who can participate?
All pregnant women from the target communities in Dublin were eligible to participate. 233 pregnant were recruited into the PFL Programme between January 2008 and August 2010.
What does the study involve?
On recruitment during pregnancy, participants were randomly assigned to either a low-treatment group or a high-treatment group. In addition, 99 pregnant women were recruited into a comparison group from a comparable community. Both the high and low treatment groups receive 100 worth of developmental toys annually and facilitated access to one year of high-quality preschool. In addition, the high-treatment group will receive two additional supports that are not available to the low-treatment group. First, participants in the high-treatment group receive home-visiting mentoring support. The home visit aims to support and help the parents with key parenting issues. Secondly, participants in the high-treatment group also participate in the Triple P Positive Parenting Programme which aims to improve positive parenting in a group-based setting for eight consecutive weeks. Data collected from all three groups (high treatment, low treatment, comparison group) at baseline during pregnancy (t0), and when the child is six months (t1), 12 months (t2), 18 months (t3), 24 months (t4), three years (t5), and four years old (t6) are compared. To determine if the effects of the programme are sustained later in childhood, data are collected from the high and low treatment groups at 7-11 years (age 9 on average) and ~age 14 as part of a follow-up study.
What are the possible benefits and risks of participating?
If the programme is effective, families in the high-treatment group may benefit by gaining greater parenting knowledge and skills and their children will be better prepared for school. The risks of participation are few. The main risk is that some study questions are personal and may cause discomfort or stress to the participant.
Where is the study run from?
The study is run from the Geary Institute at the University College Dublin, Ireland.
When is the study starting and how long is it expected to run for?
Recruitment took place from 2008 to 2010. The evaluation continues until all children are 4 years of age, in March 2015.
A follow-up study from January 2019 to September 2019 examines the impact of receiving the PFL programme between the ages of 0 and 5 on children’s outcomes later in childhood (approximately age 9).
A follow-up study from Sept 2023 to May 2024 examines the impact of receiving the PFL programme between the ages of 0 and 5 on children’s outcomes later in childhood (approximately age 14).
Who is funding the study?
The study is funded by the Northside Partnership through the Department of Children and Youth Affairs, Ireland and the Atlantic Philanthropies (USA)
The follow-up study at about age 9 and age 14 is funded by the Northside Partnership
Who is the main contact?
Dr Orla Doyle
orla.doyle@ucd.ie
Contact information
Scientific
UCD Geary Institute & School of Economics
University College Dublin
Belfield
Dublin
4
Ireland
| Phone | +353 (0)1716 4637 |
|---|---|
| orla.doyle@ucd.ie |
Study information
| Study design | Randomized controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Home, Other |
| Study type | Prevention, Quality of life |
| Participant information sheet | Patient information can be found at http://www.preparingforlife.ie/parents-resources/participants-information |
| Scientific title | A randomised trial to determine the effectiveness of the Preparing For Life programme which aims to improve the school readiness skills of socioeconomically disadvantaged children in Dublin, Ireland |
| Study acronym | PFL |
| Study objectives | Current study hypothesis as of 12/12/2023: It is hypothesised that the children participating in the Preparing for Life Programme will be significantly better prepared for school than those in the control group. For the Age 9 follow-up study, it is hypothesised that children who participated in the Preparing for Life Programme will have significantly better child health and development outcomes than those in the control group. For the Age 14 follow-up study, it is hypothesised that children who participated in the Preparing for Life Programme will have significantly better child health and development outcomes than those in the control group. The null hypothesis for the follow-up study is that there will be no difference in children’s health and development outcomes between treatment groups; this may arise if the impacts of the intervention are not sustained. Previous study hypothesis as of 24/01/2019 to 12/12/2023: It is hypothesised that the children participating in the Preparing for Life Programme will be significantly better prepared for school than those in the control group. For the Age 9 follow-up study, it is hypothesised that children who participated in the Preparing for Life Programme will have significantly better child health and development outcomes than those in the control group. The null hypothesis for the follow-up study is that there will be no difference in children’s health and development outcomes between treatment groups; this may arise if the impacts of the intervention are not sustained. Previous study hypothesis: It is hypothesised that the children participating in the Preparing for Life Programme will be significantly better prepared for school than those in the control group. The null hypothesis is that there will be no difference in school readiness between treatment groups; this may arise if the intervention is not effective or if there is contamination between groups. |
| Ethics approval(s) |
1. Approved 08/05/2008, UCD Human Research Ethics Committee (University College Dublin, Dublin 4, -, Ireland; +35317162000; hrec@ucd.ie), ref: HS-07-26-Harmon-Doyle 2. Approved 11/12/2018, UCD Human Research Ethics Committee (University College Dublin, Dublin 4, -, Ireland; +35317162000; hrec@ucd.ie), ref: HS-18-90-Doyle: Preparing for Life Age 9 Follow-Up Study 3. Approved 01/10/2023, UCD Human Research Ethics Committee (University College Dublin, Dublin 4, -, Ireland; +35317162000; hrec@ucd.ie), ref: HS-23-47-Doyle: Preparing for Life Age 14 Follow-Up Study |
| Ethics approval additional information | The Rotunda Hospital Ethic Committee, 12/05/2008 National Maternity Hospital ethic committee 28/07/2008 |
| Health condition(s) or problem(s) studied | School readiness |
| Intervention | Current interventions as of 12/12/2023: On recruitment during pregnancy, participants were randomly assigned to either a low-treatment group or a high-treatment group. High and low-treatment groups receive 100 euros worth of developmental toys annually and facilitated access to one year of high-quality preschool. The high-treatment group will receive three additional services. First, participants in the high-treatment group receive a home-visiting mentoring support service starting during pregnancy and continuing until the children start school at age 4/5. Secondly, participants in the high-treatment group participate in group parent training when the target child is 3 years old. Thirdly, participants in the high-treatment group will receive baby massage classes in the first year. Previous interventions: On recruitment during pregnancy, participants were randomly assigned to either a low-treatment group or a high-treatment group. High- and low-treatment groups receive 100 worth of developmental toys annually and facilitated access to one year of high-quality preschool. The high-treatment group will receive two additional services. First, participants in the high-treatment group receive a home-visiting mentoring support service starting during pregnancy and continuing until the children start school at age 4/5. Secondly, participants in the high-treatment group participate in group parent training when the target child is 3 years old. |
| Intervention type | Behavioural |
| Primary outcome measure | Current primary outcome measures as of 12/12/2023: School Readiness Skills 1. Cognitive development: measured using Ages and Stages Questionnaire (at 6, 12, 18, 24, 36, 48 months); Developmental Profile 3 (at 12, 18, 24, 36, 48); British Ability Scales (at 48 months); Executive functioning & delay of gratification (48 months) 2. Physical health and motor skills: measured using Ages and Stages Questionnaire (at 6, 12, 18, 24, 36, 48 months); hospital records (at 48 months); parent-reported child health (at 6, 12, 18, 24, 36, 48 months) 3. Socio-emotional development: measured using Temperament and Atypical Behaviour Scale (at 12 months); Difficult temperament (at 6 & 12 months); ASQ-Socio-Emotional scale (at 6, 12, 18, 24, 36, 48 months); Brief Infant Toddler 4. Social and Emotional Assessment (at 12, 18 24, 36 months) 4. Behavioural skills: measured using Temperament and Atypical Behaviour Scale (at 12 months); Child Behaviour Checklist (at 18, 36, 48 months); Peer Problems and Prosocial Behaviour (at 48 months) 5. Language development and emergent literacy: measured using Mac-Arthur Bates Communicative Development Inventories (at 12, 18, 24 months); Ages and Stages Questionnaire (at 6, 12, 18, 24, 36, 48 months); British Ability Scales (at 48 months) Age 9 follow-up study, Child Health and Development Outcomes (~age 9) 1. Cognitive development measured using British Ability Scales; Executive functions NIH Toolbox measures: Flanker task, dimensional change card sort task, & list sorting task 2. Physical health and motor skills: parent-reported child health, measured height & weight, Harvard step-test 3. Socio-emotional development measured using parent-report Brief Problems Monitor, Strengths and Difficulties Questionnaire, and child self-report of problem behaviours using Social Skills Improvement System 5. School attendance and performance measured using standardised test score data from primary schools (SIGMA/MICRA-T or Drumcondra tests), school attendance records, and resource supports 6. Differential susceptibility measured using DNA sampling through a non-invasive saliva swab procedure Age 14 follow-up study, Child Health and Development Outcomes (~age 14) 1. Cognitive development measured using British Ability Scales; Executive functions NIH Toolbox measures: Flanker task, dimensional change card sort task, & list sorting task 2. Physical health: Measured height & waist measurements 3. Child self-complete interview: Socio-emotional skills, health behaviors, puberty development, school behaviors, time use, parental attachment, antisocial behaviour, risk preferences, time preferences 6. Biological ageing measured using DNA sampling through a non-invasive saliva procedure Previous primary outcome measures as of 24/01/2019 to 12/12/2023: School Readiness Skills 1. Cognitive development: measured using Ages and Stages Questionnaire (at 6, 12, 18, 24, 36, 48 months); Developmental Profile 3 (at 12, 18, 24, 36, 48); British Ability Scales (at 48 months); Executive functioning & delay of gratification (48 months) 2. Physical health and motor skills: measured using Ages and Stages Questionnaire (at 6, 12, 18, 24, 36, 48 months); hospital records (at 48 months); parent-reported child health (at 6, 12, 18, 24, 36, 48 months) 3. Socio-emotional development: measured using Temperament and Atypical Behaviour Scale (at 12 months); Difficult temperament (at 6 & 12 months); ASQ-Socio-Emotional scale (at 6, 12, 18, 24, 36, 48 months); Brief Infant Toddler 4. Social and Emotional Assessment (at 12, 18 24, 36 months) 4. Behavioural skills: measured using Temperament and Atypical Behaviour Scale (at 12 months); Child Behaviour Checklist (at 18, 36, 48 months); Peer Problems and Prosocial Behaviour (at 48 months) 5. Language development and emergent literacy: measured using Mac-Arthur Bates Communicative Development Inventories (at 12, 18, 24 months); Ages and Stages Questionnaire (at 6, 12, 18, 24, 36, 48 months); British Ability Scales (at 48 months) Age 9 follow-up study, Child Health and Development Outcomes (~age 9) 1. Cognitive development measured using British Ability Scales; Executive functions NIH Toolbox measures: Flanker task, dimensional change card sort task, & list sorting task 2. Physical health and motor skills: parent-reported child health, measured height & weight, Harvard step-test 3. Socio-emotional development measured using parent-report Brief Problems Monitor, Strengths and Difficulties Questionnaire, and child self-report of problem behaviours using Social Skills Improvement System 5. School attendance and performance measured using standardised test score data from primary schools (SIGMA/MICRA-T or Drumcondra tests), school attendance records, and resource supports 6. Differential susceptibility measured using DNA sampling through a non-invasive saliva swab procedure Previous primary outcome measures: School Readiness Skills 1. Cognitive development: measured using Ages and Stages Questionnaire (at 6, 12, 18, 24, 36, 48 months); Developmental Profile 3 (at 12, 18, 24, 36, 48); British Ability Scales (at 48 months); Executive functioning & delay of gratification (48 months) 2. Physical health and motor skills: measured using Ages and Stages Questionnaire (at 6, 12, 18, 24, 36, 48 months); hospital records (at 48 months); parent-reported child health (at 6, 12, 18, 24, 36, 48 months) 3. Socio-emotional development: measured using Temperament and Atypical Behaviour Scale (at 12 months); Difficult temperament (at 6 & 12 months); ASQ-Socio-Emotional scale (at 6, 12, 18, 24, 36, 48 months); Brief Infant Toddler 4. Social and Emotional Assessment (at 12, 18 24, 36 months) 4. Behavioural skills: measured using Temperament and Atypical Behaviour Scale (at 12 months); Child Behaviour Checklist (at 18, 36, 48 months); Peer Problems and Prosocial Behaviour (at 48 months) 5. Language development and emergent literacy: measured using Mac-Arthur Bates Communicative Development Inventories (at 12, 18, 24 months); Ages and Stages Questionnaire (at 6, 12, 18, 24, 36, 48 months); British Ability Scales (at 48 months) |
| Secondary outcome measures | 1. Birth outcomes: maternity hospital records at birth (birth weight, gestational age, prematurity, Apgar score) 2. Labour outcomes: maternity hospital records at birth (instrumental delivery, caesarean section- elective, emergency 3. Parenting skills: Adult Adolescence Parenting Inventory (at baseline &12 months); Knowledge of Infant Development (at baseline & 12 months); Parental locus of control (at 6 months); Condon Maternal Attachment Scale (at 6 & 24 months); Parenting Stress Index (at 6, 24 & 48 months); Parenting Daily Hassles Scale (at 18, 36 & 48 months).; Maternal Separation Anxiety (at 18 months); Parental Cognitions and Conduct Towards Infant Scale (at 6 & 24 months); Parenting Styles and Dimensions Questionnaire (at 36 & 48 months); Parental Acceptance -Rejection Questionnaire (at 36 months) 4. Quality of the home environment: Home Observation for Measurement of the Environment scale (at 6, 18 & 36 months); Activities with child (at 6, 18, 36 months); Home Learning Environment (at 48 months); Material Deprivation scale (at 18 months); Framingham Safety Survey (at 6, 18, & 48 months); Family Environment Scale (at 12 &36 months); Difficult Life Circumstances (18 & 36 months); Neighbourhood Quality Evaluation Scale (at 36 months); Family Routine Inventory (at 36 months) 5. Parent health: physical health outcomes (self-reported) (at baseline, 6, 12, 18, 24, 36, 48 months); personality (Tem-Item Personality Inventory (baseline), Rosenberg self-esteem (at baseline12, 18, 48 months) Pearlin Self-Efficacy Scale (at baseline,12 & 48 months) ; Vulnerable Attachment Style Questionnaire (baseline); Considerations of Future Consequences (at baseline & 24 months); Future Outlook Inventory (at 12, 36 months); Self-control (at 18 months); mental health outcomes (Edinburgh Postnatal Depression Scale at 6, 18, 24, 36, & 48); WHO-5 Index (at baseline, 6, 12, 36, 48) 6. Social support and service use: Level from support from various people (at 6, 18, 24, 36, & 48 months); community integration (at 6, 12, 18, 24, 36, 48 months); use of services (at 6, 18, 36 months); partner satisfaction (at 6, 12, 24, 48 months); Maternal Social Support Index ( at 18 & 36 month); Family Quality of Life (at 36 months); Relationship Quality Index (at 36 months) Added 24/01/2019: Age 9 follow-up study (~age 9) 1. Quality of the home environment measured using Family Involvement Questionnaire 2. Parental attention measured using Attentional Control Scale |
| Overall study start date | 31/07/2008 |
| Completion date | 30/10/2024 |
Eligibility
| Participant type(s) | Patient, Population |
|---|---|
| Age group | Adult |
| Lower age limit | 16 Years |
| Sex | Female |
| Target number of participants | 300 |
| Total final enrolment | 233 |
| Key inclusion criteria | 1. Women (age 16+ years) pregnant between 2008 and 2010 2. Residing in the PFL catchment area 3. Willing to be assigned to either of the study intervention groups |
| Key exclusion criteria | Potential participants were excluded if they did not meet inclusion criteria |
| Date of first enrolment | 31/07/2008 |
| Date of final enrolment | 30/03/2015 |
Locations
Countries of recruitment
- Ireland
Study participating centre
4
Ireland
Sponsor information
University/education
Belfield
Dublin
4
Ireland
| Phone | +353 (0)1716 4615 |
|---|---|
| geary@ucd.ie | |
| Website | http://www.ucd.ie/ |
"ROR" |
https://ror.org/05m7pjf47 |
Funders
Funder type
Government
No information available
Results and Publications
| Intention to publish date | 01/05/2025 |
|---|---|
| Individual participant data (IPD) Intention to share | Yes |
| IPD sharing plan summary | Stored in publicly available repository |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan | The datasets generated during and/or analysed during the current study will be stored in a publically available repository. Participant level data for the evaluation to date from 2008-2015 is already available in the Irish Social Science Data Archive (https://www.ucd.ie/issda/data/pfl/). Consent to anonymise the 2008-2015 data was sought on recruitment into the PFL programme and evaluation. For the age 9 follow-up study, participant level data will also be archived within the Irish Social Science Data Archive once the study is complete. The will be available for research purposes through the ISSDA application process. Consent to anonymise and archive the data is sought from participants when they are asked to take part in the Age 9 follow-up study. |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Protocol article | protocol | 18/04/2012 | Yes | No | |
| Other publications | analysis of programme engagement | 01/01/2014 | Yes | No | |
| Results article | perinatal results | 01/09/2014 | Yes | No | |
| Results article | child health results | 01/12/2015 | Yes | No | |
| Other publications | process evaluation | 01/01/2016 | Yes | No | |
| Other publications | resilience and children’s perspectives | 01/04/2016 | Yes | No | |
| Results article | socioemotional results | 02/06/2016 | Yes | No | |
| Results article | dietary intake results | 01/01/2017 | Yes | No | |
| Results article | well-being results | 17/01/2017 | Yes | No | |
| Other publications | children’s perspectives school experiences | 04/03/2017 | Yes | No | |
| Other publications | early life outcomes | 01/04/2017 | Yes | No | |
| Other publications | maternal warmth and toddler development | 01/04/2017 | Yes | No | |
| Other publications | children’s perspectives on toileting | 01/06/2017 | Yes | No | |
| Other publications | cognitive and socioemotional results | 18/08/2017 | Yes | No | |
| Results article | archiving results | 01/01/2018 | Yes | No | |
| Results article | shared book reading results | 01/01/2018 | Yes | No | |
| Results article | behaviour, cognition, and health results | 01/05/2018 | Yes | No | |
| Results article | results | 01/07/2019 | 08/07/2020 | Yes | No |
| Results article | Child skills | 16/04/2020 | 12/12/2023 | Yes | No |
Editorial Notes
01/05/2024: The following changes were made to the study record:
1. The overall study end date was changed from 30/05/2024 to 30/10/2024.
2. The intention to publish date was added.
12/12/2023: The following changes were made:
1. Publication reference added.
2. The study hypothesis was changed.
3. Ethics approval was added for the Preparing for Life Age 14 Follow-Up Study
4. Home was added as a study setting.
5. Prevention was added as a study type.
6. The overall study end date was changed from 01/10/2019 to 30/05/2024.
7. The interventions were changed.
8. The intervention type was changed from Other to Behavioural.
9. The primary outcome measures were updated.
10. Population was added as a participant type.
11. Total final enrolment added.
12. The plain English summary was updated to include the age 14 follow-up study.
08/07/2020: Publication reference added.
25/01/2019: IPD sharing statement added.
24/01/2019: The following changes were made to the trial record:
1. The study hypothesis, ethics approval, and primary and secondary outcome measures fields were updated to include the age 9 follow-up study.
2. The overall trial end date was changed from 30/03/2015 to 01/10/2019.
3. Publication references added.
03/06/2016: Publication reference added.
